TFE3 and renal cell carcinoma: When RCCs was classified as TFE3-negative RCC, Xp11.2 translocation RCC, and TFE3-positive non-Xp11.2 translocation RCC groups, it was evident that the TFE3-negative RCC group had a significantly longer progression-free survival as compared with the other groups.